3D Tissue Models

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors Review type Summary Keywords File filename File mime type
1. 2012 Evaluation of reliability, validation and responsiveness of the CDASI and the CAT-BM. J Invest Dermatol. 132:1117-24, 2012
2. 2011 Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis J Rheumatol. 38:1326-8, 2011.
3. 2010 A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity J Invest Dermatol. 130:694-705, 2010
4. 2009 Molecular framework for response to imatinib mesylate in systemic sclerosis Arthritis Rheum. 60:581-91, 2009
5. 2008 Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol. 159:887-94, 2008
6. 2008 Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease Resp Med. 102:150-5, 2008.
7. 2008 Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PloS ONE. 16:e1452, 2008
8. 2008 Stem cell transplant for myelodysplastic syndrome-associated, treatment-refractory, histiocytoid sweet’s syndrome Arthritis Rheum. 59:1832-4, 2008
9. 2008 The stiff skin syndrome: case series, differential diagnosis of the stiff skin phenotype and review of the literature. Arch Dermatol. 144:1351-9, 2008
10. 2008 Molecular subsets in the gene expression signatures of scleroderma skin PloS ONE 16;2696, 2008
11. 2007 Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 176:1026-34, 2007
12. 2007 Diagnosis of Muckle-Wells syndrome – 33 years later. J Rheumatol. 34:2505-6, 2007
13. 2007 Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007;66:1641-7
14. 2007 Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study Arthritis Rheum. 56:1676-84, 2007
15. 2006 An unusual presentation of amyopathic dermatomyositis associated with interstitial lung disease Arch Dermatol. 142:113-4, 2006.
16. 2006 Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome Pain. 120:244-66, 2006
17. 2006 Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog J Am Acad Dermatol. 54:S58-9, 2006
18. 2006 Cycloposphamide versus Placebo in Scleroderma Lung Disease. N Engl J Med. 354:2655-66, 2006
19. 2005 Correlation of the degree of dyspnea score with heath-related quality of life, functional abilities and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study Arthritis Rheum. 52:592-600, 2005
20. 2005 The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease Arch Dermatol. 141:242-247, 2005
21. 2004 Aberrant serum hyaluronan and hyaluronidase levels in scleroderma Br J Dermatol. 150:469-476, 2004.
22. 2004 Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus Lupus. 13:839-849, 2004.
23. 2003 Systemic and cell type-specific gene expression patterns in scleroderma skin Proc Natl Acad Sci USA. 100:12319-12324, 2003
24. 2003 Peripheral neuropathy in scleroderma Muscle Nerve. 28:330-335, 2003
25. 2002 Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts Arthritis Rheum. 46:1857-1865, 2002.
26. 2002 Renal insufficiency with monoclonal gammopathy and urticarial vasculitis Am J Kidney Dis. 39:203-207, 2002
27. 2001 Celecoxib-induced Sweet’s syndrome J Am Acad Dermatol. 45:300-302, 2001
28. 2000 Detection of type 1 cytokines in discoid lupus erythematosus. Arch Dermatol. 136:1497-1501, 2000
29. 1999 Endoglin, a transforming growth factor beta receptor III, is upregulated in scleroderma dermal fibroblasts J Invest Dermatol. 112:587, 1999.
30. 1998 Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol. 161:4688-4694, 1998.
31. 1998 Fetal DNA and cells in women with systemic sclerosis (letter) N Engl J Med. 339:771-772, 1998.
32. 1998 Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice Clin Immunol Immunopathol. 87:23-32, 1998
33. 1997 Evidence for TH1 cytokines in tissue inflammation in discoid lupus J Invest Dermatol. 108:639, 1997.
34. 1997 Fibrosis in scleroderma is mediated by a secreted protein, fibrosin that acts as an autocrine growth factor J Invest Dermatol. 108:546, 1997
35. 1996 Fibrosis in scleroderma is mediated by a dysregulated autocrine loop involving a novel fibrogenic cytokine, fibrosin In 2nd joint Meeting of the Wound Healing Society and European Tissue Repair Society. 1996.
36. 1996 Cutaneous innervation density in the allodynic form of postherpetic neuralgia Neurobiol Dis. 3:205-214, 1996
37. 1996 Alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases Immunity. 5:429-436. 1996
38. 1995 Gottron’s papules? Acanthosis nigricans Arthritis Rheum. 38:862-865, 1995.
39. 1994 Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy Clin Immunol Immunopathol. 72:198-203, 1994.
40. 1994 The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol. 130:1278-1283, 1994.
41. 1992 Development of autoantibodies in a SCID model of murine lupus Arthritis Rheum. 35:S9, 1992.
42. 1992 Regulation of autoantibody production in a SCID model of lupus Clin Res 40:198A, 1992.
43. 1992 Development of murine lupus in CD4-depleted ZB/NZW mice: Sustained inhibition of residual CD4+T cells is required to suppress autoimmunity J Immunol. 149:3083-3088, 1992.
44. 1991 The thymus retains the ability to deplete autoreactive T cells in aged normal and autoimmune mice Arthritis Rheum. 34:S185, 1991

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.